Preclinical comparison of the blood brain barrier (BBB) permeability of osimertinib (AZD9291) with other irreversible next generation EGFR TKIs von Colclough, N, Ballard, P.G, Barton, P, Chen, K, Cross, D.A.E, Finlay, M.R.V, Han, L, Janefeldt, A, Johnström, P, Ward, R.A, Wrigley, G.L, Yan, Y, Yates, J.W.T, Zhang, D, Zhang, Z

Volltext

64 - Preclinical comparison of the blood brain barrier (BBB) permeability of osimertinib (AZD9291) with other irreversible next generation EGFR TKIs von Colclough, N., Ballard, P.G., Barton, P., Chen, K., Cross, D.A.E., Finlay, M.R.V., Han, L., Janefeldt, A., Johnström, P., Ward, R.A., Wrigley, G.L., Yan, Y., Yates, J.W.T., Zhang, D., Zhang, Z.

Volltext

Identification of novel vascular targets in lung cancer von Zhuang, X, Herbert, J.M.J, Lodhia, P, Bradford, J, Turner, A.M, Newby, P.M, Thickett, D, Naidu, U, Blakey, D, Barry, S, Cross, D.A.E, Bicknell, R

Volltext bestellen